Navigation Links
Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals
Date:12/31/2013

rs of the Perrigo Board of Directors. The Company stated that the appointment of the Company's Board follows the completion of its acquisition of Elan Corporation, plc, in a transaction valued at approximately $8.6 billion. The Full Research Report on Perrigo Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/4168_PRGO

--

Arena Pharmaceuticals, Inc. Research Report

On December 26, 2013, Arena Pharmaceuticals, Inc.'s (Arena Pharmaceuticals) stock went up by 6.03%, to close at $5.98. The Company's stock went rose 7.36% over the previous three trading sessions, compared to the Dow Jones Industrial Average, which advanced 1.60% during the same trading period. The Full Research Report on Arena Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/6a95_ARNA

--

Keryx Biopharmaceuticals Inc. Research Report

On December 18, 2013, Keryx Biopharmaceuticals Inc. (Keryx) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 8,609,896, which will expire in 2024. According to the Company, the patent claims orally administrable forms of Zerenex prepared from ferric citrate having a BET active surface area greater than about 16 sq. m/g. Keryx informed that the active pharmaceutical ingredient of Zerenex is ferric citrate having a BET surface area substantially above this surface area threshold. Ron Bentsur, CEO of Keryx, commented, "We believe that our portfolio of patents will provide market exclusivity for Zerenex through at least 2024, as the high API surface area
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
2. California Biomedical Companies Report Higher Product Approvals, Fewer Delays
3. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge
4. Synthetic Biologics Announces Proposed Public Offering of Common Stock
5. MiMedx Group Announces Proposed Public Offering of Common Stock
6. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
7. Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants
8. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
9. DURECT Announces Pricing of Public Offering of Common Stock
10. InterMune Announces Pricing of Public Offering of 6,500,000 Shares of Common Stock
11. Discovery Labs Prices $50 Million Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Industry leader iLab Solutions ... In this newly-created position, Gibbs will lead iLab’s business operations in the region, ... tools. This entails not only introducing iLab to potential partners but support and ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... of California Los Angeles, Boston University School of Medicine, Frederick National Laboratory for ... One, the world’s first multidisciplinary Open Access journal. , Christopher Ryan PhD, ...
(Date:9/1/2015)... 1, 2015 Shire plc (LSE: SHP, ... Mathew to its Board of Directors as a Non-Executive ... Compliance & Risk Committee of the Shire Board. Both appointments ... Sara previously served as Chairman, President and Chief Executive Officer ... During her 12-year tenure at D&B, she helped drive the ...
(Date:8/31/2015)... , Aug. 31, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... $5.7 million. The orders are for air emission abatement projects in ... note is a large order for a municipality in the ... be replacing a competitor,s system that failed to meet the ... engineered solutions," said Derek S. Webb , President and ...
Breaking Biology Technology:iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Shire Appoints Sara Mathew to Board of Directors 2
... PLYMOUTH MEETING, Pa., March 17 /PRNewswire-Asia-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: ... for the fourth quarter and fiscal year ended,December 31, 2008. , ... -- Fourth quarter revenues increased to $36.6 million, ... fourth quarter of 2007., -- Non-GAAP operating income, ...
... Biotek, an innovative Canadian biotechnology company focusing primarily ... protein purification, today announced the signing of an ... "EXQ") to supply RNA purification kits based on ... Denmark-based company active in the life sciences, diagnostics ...
... of 25 February 2009, Arpida communicated that the Board of ... the company,s future. , In preparation ... to update shareholders as follows: At the shareholders, meeting, the,Board ... following options or a combination thereof: , , ...
Cached Biology Technology:BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 2BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 3BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 4BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 5BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 6BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 7BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 8BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 9BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 10BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 11BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results 12Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S 2Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S 3Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S 4Board Reviews Strategic Options to Present to Shareholders at Shareholders' Meeting 2
(Date:8/6/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced collaboration with Microsoft on biometric fingerprint ... leveraged Synaptics, deep expertise in human interface which ... Through stringent testing, Synaptics, advanced image sensing ... Precision TouchPad (PTP) specification empowering OEMs with Windows ...
(Date:8/5/2015)... The biosensors market is proving highly attractive ... newer sectors, and development of devices resulting in higher ... seen the entry of multiple participants each year with ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) Recent ... Global Biosensors Market ( http://www.frost.com/nee9 ), finds that ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. ... interface solutions, today announced that members of the executive ... the Pacific Crest Global Technology Leadership Forum on Tuesday, ... conference will be held at the Sonnenalp Resort in ... The presentation may include forward-looking information. An audio webcast ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... from the Midlands Consortium say they are absolutely ... been chosen to host a new 1billion national ... Consortium is comprised of the universities of Birmingham, ... with extensive and complementary energy related research activities. ...
... in primates suggests that infants and children who carry ... the ill effects of fetal alcohol exposure. Reported ... represent the first evidence of a genetic risk for ... characterized by profound mental retardation in its most severe ...
... be the place to be on September 27 and 28, ... to present their news. The second Future of Male ... Health and Human Development, CONRAD, the World Health Organization, and ... Hotel overlooking the Puget Sound. Registration is free of ...
Cached Biology News:Midlands Consortium delighted to be chosen to host £1 billion energy institute 2Midlands Consortium delighted to be chosen to host £1 billion energy institute 3Study reveals possible genetic risk for fetal alcohol disorders 2Study reveals possible genetic risk for fetal alcohol disorders 3
Vitronectin Immunogen: Purified, full length, native human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Guava has made microcapillary flow cytometry accessible ... experts alike will appreciate the latest addition ... Pluseasy to use, surprising affordable, and very ... system includes such features as absolute cell ...
...
Fingerprinting II Basic software is used for analyzing fingerprint sample types (electrophoretic gels, HPLC and other chromatographic patterns, spectrophotometric and densitometric curves)....
Biology Products: